20664 Federal Register / Vol. 66, No. 79 / Tuesday, April 24, 2001 / Notices

Dated: April 18, 2001.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC)

[FR Doc. 01–10055 Filed 4–23–01; 8:45 am]

BILLING CODE 4163–19–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Disease, Disability, and Injury

Prevention and Control Special

Emphasis Panel (SEP): NORA: RFA

OH–01–007: Community-Based

Interventions to Prevent Childhood

Agricultural Injury and Disease

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following meeting:

Name: Disease, Disability, and Injury

Prevention and Control Special

Emphasis Panel (SEP) NORA: RFA OH–

01–007: Community-Based

Interventions to Prevent Childhood

Agricultural Injury and Disease.

Times and Dates: 5 p.m.–5:30 p.m.,

May 15, 2001. (Open); 5:30 p.m.–9 p.m.,

May 15, 2001. (Closed); 8 a.m.–5 p.m.,

May 16, 2001. (Closed).

Place: State Plaza Hotel, 2117 E. State

Street, NW, Washington, DC 20037.

Status: Portions of the meeting will be

closed to the public in accordance with

provisions set forth in section 552b(c)

(4) and (6), Title 5 U.S.C., and the

Determination of the Deputy Director for

Program Management, CDC, pursuant to

Public Law 92–463.

Matters to be Discussed: The meeting

will include the review, discussion, and

evaluation of applications received in

response to Program Announcement

NORA: RFA OH–01–007.

Contact Person for More Information:

Gwendolyn H. Cattledge, Ph.D., Office

of Extramural Programs, National

Institute for Occupational Safety and

Health, CDC, 1600 Clifton Rd, NE, M/S

D28, Atlanta, Georgia 30333, telephone

404–639–2378.

The Director, Management Analysis

and Services Office has been delegated

the authority to sign Federal Register

notices pertaining to announcements of

meetings and other committee

management activities, for both the

Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: April 12, 2001.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 01–10057 Filed 4–23–01; 8:45 am]

BILLING CODE 4163–19–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Notice of Meeting

National Center for Health Statistics

(NCHS), Data Policy and Standards

Staff, announces the following meeting.

Name: ICD–9–CM Coordination and

Maintenance Committee meeting.

Time and Date: 9 a.m.–5 p.m., May

17–18, 2001.

Place: The Health Care Financing

Administration, Auditorium, 7500

Security Boulevard, Baltimore,

Maryland. In the interest of security, the

H.C.F.A. has instituted stringent

procedures for entrance into the

building by non-government employees.

Persons without a government I.D. will

need to show a photo I.D. and sign-in at

the security desk upon entering the

building.

Status: Open to the public, as limited

by the capacity of the meeting room,

which is 75 people.

Purpose: The ICD–9–CM Coordination

and Maintenance (C&M) Committee will

hold its first meeting of the 2001

calendar year cycle on Thursday and

Friday May 17–18, 2001. The C&M

meeting is a public forum for the

presentation of proposed modifications

to the International Classification of

Diseases, Ninth-Revision, Clinical

Modification.

Matters to be Discussed: Agenda items

include:

Critical illness neuropathy

Ocular torticollis

Personal history of pre-term labor

Fussy infant/excessive crying of infant

Perinatal conditions

Aqueous misdirection

Disruption of operation wound

Dieulafoy lesion

Aftercare codes

Supplemental oxygen dependency

Scooter external cause code

Implementation issues on the ICD–

10–Procedure Classification System

(PCS) coding system. Presenters will

include:

The American Health Information

Management Association (AHIMA)

The American Hospital Association

(AHA)

The American Medical Association

(AMA)

McKesson HBOC

DRG Review, Inc.

AdvaMed

Ingenix Syndicated Content Group

Princeton Provider Group

ICD–9–CM procedure topics to be

covered:

High-Dose Interleukin-2

Spinal Fusion Devices

Addenda

Contact Person for Additional

Information: Amy Blum, Medical

Classification Specialist, Data Policy

and Standards Staff, NCHS, 6526

Belcrest Road, Room 1100, Hyattsville,

Maryland 20782, telephone 301/458–

4106 (diagnosis), Amy Gruber, Health

Insurance Specialist, Division of Acute

Care, HCFA, 7500 Security Blvd., Room

C4–07–07, Baltimore, Maryland, 21244

telephone 410–786–1542 (procedures).

The Director, Management Analysis

and Services Office, has been delegated

the authority to sign Federal Register

notices pertaining to announcements of

meetings and other committee

management activities, for both CDC

and the Agency for Toxic Substances

and Disease Registry.

Dated: April 18, 2001.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention.

[FR Doc. 01–10056 Filed 4–23–01; 8:45 am]

BILLING CODE 4160–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 01N–0167]

Preparation for ICH Meetings in Tokyo,

Japan, Including Progress on the

Common Technical Document and

Possibilities for New Topics; Notice of

Public Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice of public meeting.

SUMMARY: The Food and Drug

Administration (FDA) is announcing a

public meeting entitled ‘‘Preparation for

ICH Meetings in Tokyo, Japan,

Including Progress on the Common

Technical Document and Possibilities

for New Topics,’’ to solicit information

and receive comments on the future of

the International Conference on

Harmonisation (ICH) as well as the

upcoming meetings in Tokyo, Japan.

The topic to be discussed is the